BACKGROUND AND PURPOSE
Type II Diabetes mellitus (T2DM) is a worrying chronic metabolic disorder accompanied by multiple serious complications, makes threaten public health. In the present study, we evaluated the therapeutic effects against T2DM of the cycloastragenol (CAG ), a key metabolite of astragaloside IV (AST ) isolated from traditional Chinese plant Astragalus membranaceus and revealed its molecular mechanism.